| Tumor resident memory T cells: new players in immune surveillance and therapy N Dumauthioz, S Labiano, P Romero Frontiers in immunology 9, 411458, 2018 | 102 | 2018 |
| Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity N Dumauthioz, B Tschumi, M Wenes, B Marti, H Wang, F Franco, W Li, ... Cellular & molecular immunology 18 (7), 1761-1771, 2021 | 90 | 2021 |
| The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function M Wenes, A Jaccard, T Wyss, N Maldonado-Pérez, ST Teoh, A Lepez, ... Cell Metabolism 34 (5), 731-746. e9, 2022 | 81 | 2022 |
| CART cells are prone to Fas-and DR5-mediated cell death BO Tschumi, N Dumauthioz, B Marti, L Zhang, P Schneider, JP Mach, ... Journal for immunotherapy of cancer 6 (1), 71, 2018 | 80 | 2018 |
| PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions G Ercolano, A Gomez-Cadena, N Dumauthioz, G Vanoni, M Kreutzfeldt, ... Nature communications 12 (1), 2538, 2021 | 57 | 2021 |
| PGC-1 alpha engineered CD8 T cell for enhanced anti-tumor immunity N Dumauthioz, B Tschumi, M Wenes, H Wang, F Franco, I Lopez-Mejia, ... SWISS MEDICAL WEEKLY, 23S-24S, 2019 | | 2019 |
| Understanding the susceptibility of CART cells to Fas-and DR5-mediated cell death C Godfroid, BO Tschumi, N Dumauthioz, B Marti, L Zhang, P Schneider, ... SWISS MEDICAL WEEKLY, 24S-24S, 2019 | | 2019 |
| Enforced PGC-1 alpha expression promotes CD8 T cell persistence and anti-tumor immunity N Dumauthioz, B Tschumi, M Wenes, I Lopez-Mejia, L Fajas, A Donda, ... SWISS MEDICAL WEEKLY 148, 4S-5S, 2018 | | 2018 |
